Table 1 Comparison on demographic and clinical data for NPE and CNSD children patients

N

42

47

Age (months, \( \bar{x} \pm s \))

17.55 ± 5.12

22.94 ± 10.37

Boy (cases, (%))

23 (54.76)

30 (63.83)

Body mass (kg, \( \bar{x} \pm s \))

11.86 ± 2.02

12.72 ± 2.71

Residence

 City

10 (23.81)

13 (27.66)

 Rural area

22 (52.38)

22 (46.81)

 Rural–urban fringe zone

10 (23.81)

12 (25.53)

Length of stay (days) median (P25 and P75)

8 (6,9)

6 (5,7)

Maximum body temperature (°C, \( \bar{x} \pm s \))

38.89 ± 0.60

38.73 ± 0.80

Duration of fever (days) median (P25 and P75)

4 (4,5)

3 (2,4)

Cardiac rhythm (times/min, \( \bar{x} \pm s \))

227.21 ± 28.23

161.09 ± 23.31

EV71-positive cases (%)

37 (88.10)

29 (61.70)

White blood cell count (×109/L, \( \bar{x} \pm s \))

13.75 ± 3.68

12.84 ± 2.78

CRP (mg/L, \( \bar{x} \pm s \))

15.43 ± 10.31

9.83 ± 6.28

Blood sugar (mmol/L, \( \bar{x} \pm s \))

7.58 ± 1.83

6.16 ± 1.14

IVI therapy cases (%)

37 (88.10)

38 (80.85)

Hormonal therapy cases (%)

40 (95.24)

43 (91.49)